文献速递肝病消化道肿瘤与早癌

非酒精性脂肪性肝炎成为女性肝移植主要病因:肝移植指征及民族与性别差异的更新分析

NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
PubMed 文献 · Am J Gastroenterol · 2018-06-08

该研究基于美国器官共享联合网络/器官获取与移植网络数据库2004年1月1日至2016年12月31日登记的127,164例成人肝移植候选者,评估肝移植等待名单登记及移植的病因变化及性别与民族差异。至2016年,酒精性肝病是等待名单登记和肝移植的首要病因,非酒精性脂肪性肝炎(NASH)位居第二;NASH是女性肝移植的首要病因,在男性中位居第二(仅次于酒精性肝病)。NASH在所有民族亚组中均增加,且是2016年亚裔、西班牙裔和非西班牙裔白人女性的首要病因。

要点

  • 至2016年,酒精性肝病是肝移植等待名单登记和移植的首要病因,NASH位居第二。
  • NASH是女性肝移植的首要病因,在男性中位列第二(仅次于酒精性肝病)。
  • NASH是2016年亚裔、西班牙裔和非西班牙裔白人女性肝移植的首要病因。

核心结论

  • NASH目前是肝移植等待名单登记/肝移植的总体第二大病因,在女性中为首要病因。
  • 鉴于NASH的增长速度,NASH在男性中可能也将上升为肝移植的首要指征。

研究设计与样本

  • 研究纳入美国器官共享联合网络/器官获取与移植网络数据库中2004年1月1日至2016年12月31日登记的127,164例成人肝移植候选者。
  • 采用多项logistic回归模型检验等待名单或肝移植率的变化。

主要发现

  • 至2016年,酒精性肝病是等待名单登记和肝移植的首要病因,NASH位居第二,慢性丙型肝炎病毒(HCV)所致肝细胞癌(HCC)和单纯慢性HCV分别位列第三和第四。
  • NASH是女性肝移植的首要病因,在男性中为第二病因(仅次于酒精性肝病)。
  • NASH在所有民族亚组中作为病因均增加,且是2016年亚裔、西班牙裔和非西班牙裔白人女性的首要病因。
  • HCV所致肝细胞癌的肝移植指征多年来增加,但2015年至2016年间在男性和女性中均首次出现下降。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Chronic infection with hepatitis C virus (HCV) was previously the leading indication for liver transplant (LT) in the United States. However, since 2014 the use of direct-acting antivirals (DAAs) has decreased the chronic HCV burden, while the prevalence of nonalcoholic steatohepatitis (NASH) has risen substantially through the last decade. Both gender and ethnic disparities in indications for LT have been shown in the past but no data on this have been reported since the implementation of DAAs. METHODS: We assessed changes in etiologies for LT listing and in gender and ethnic differences in those listed for LT. Adult patients registered for LT in the United Network for Organ Sharing/Organ Procurement and Transplantation Network database between January 1, 2004 and December 31, 2016 were included. Multinomial logistic regression modeling was used to test for changes in waitlist or liver transplant rates. RESULTS: The study included 127,164 adult patients registered for LT. By 2016, alcoholic liver disease (ALD) was the leading etiology for waitlisting and LT; NASH was second; hepatocellular carcinoma (HCC) due to chronic HCV and chronic HCV alone were 3rd and 4th. NASH was the leading cause for LT for women and the 2nd leading cause for men (following ALD). NASH increased as the cause in all ethnic subgroups and was the leading cause in 2016 among Asian, Hispanic, and non-Hispanic white females. We also found that although the indication for liver transplant for hepatocellular carcinoma (HCC) due to HCV has increased over the years, this indication decreased for the first time between 2015 and 2016 in both males and females. CONCLUSIONS: NASH is currently the second leading cause for LT waitlist registration/liver transplantation overall, and in females, the leading cause. Given the rate of increase, NASH will likely rise to become the leading indication for LT in males as well.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Noureddin M, Vipani A, Bresee C, et al. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances. Am J Gastroenterol. 2018. PMID: 29880964. doi:10.1038/s41395-018-0088-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。